Citations

Showing 10 of 107961 citations.

MR staging accuracy for endometrial cancer based on the new FIGO stage
Shin, Kyung Eun , Park, Byung Kwan , Kim, Chan Kyo , Bae, Duk Soo, Song, Sang Yong, Kim, Bohyun, Kim, Bohyun

Mayo Clinic

Acta Radiologica | July 8, 2011 | Volume: 52 | Issue: 7 | Pages: 818-824

10.1258/ar.2011.100426 | PMID 21742787 Get It

Background Magnetic resonance imaging (MRI) has been frequently used to determine a preoperative treatment plan for gynecologic cancers. However, the MR accuracy for staging an endometrial cancer is not satisfactory based on the old FIGO staging system. Purpose To evaluate MR accuracy for staging endometrial cancer using the new FIGO staging system. Material and Methods Between January 2005 and May 2009, 199 women underwent surgery due to endometrial cancer. In each patient, an endometrial cancer was staged using MR findings based on the old FIGO staging system and then repeated according to the new FIGO staging system for comparison. Histopathologic findings were used as a standard of reference. Results The accuracy of MRI in the staging of endometrial carcinoma stage I, II, III, and IV using the old FIGO staging system were 80% (159/199), 89% (178/199), 90% (179/199), and 99% (198/199), respectively, compared to 87% (174/199), 97% (193/199), 90% (179/199), and 99% (198/199), respectively, when using the new FIGO staging criteria. The overall MR accuracy of the old and new staging systems were 51% (101/199) and 81% (161/199), respectively. Conclusion MRI has become a more useful tool in the preoperative staging of endometrial cancers using the new FIGO staging system compared to the old one with increased accuracy.
Nodular enhancement within the internal auditory canal following retrosigmoid vestibular schwannoma resection: a unique radiological pattern
Carlson, Matthew L. , Abel, Kathryn M. Van , Schmitt, William R., Driscoll, Colin L. W., Neff, Brian A., Lane, John I. , Link, Michael J. , Van Abel, Kathryn M

Mayo Clinic

Journal of Neurosurgery | July 8, 2011 | Volume: 115 | Issue: 4 | Pages: 835-841

10.3171/2011.6.jns11772 | PMID 21740115 Get It

Object The authors describe the unique occurrence of nodular enhancement within the fundus of the internal auditory canal (IAC) lateral to the preoperative radiological tumor margin following gross-total vestibular schwannoma (VS) resection. Methods The nature of the study was a retrospective chart review of records. The authors reviewed the cases of all patients who underwent microsurgical resection of a VS between January 2000 and January 2010 at a single tertiary referral center. Patients with incomplete resection, neurofibromatosis Type 2, and those with fewer than 2 postoperative MR images available for review were excluded. Postsurgical patients with IAC enhancement located lateral to the preoperative imaging–delineated tumor margin were identified. Lesion morphology was characterized on serial MR imaging studies. Clinical follow-up and outcomes were recorded. Results Over the past decade, 350 patients underwent microsurgical VS resection. Of these, 16 patients met study criteria and were found to have postsurgical enhancement in the distal aspect of the IAC lateral to the imaging limits of the preoperative tumor margin on the first postoperative MR imaging study (37.5% women, median age 45 years). Initial MR imaging was performed at a mean of 3.1 months following surgery, and the mean radiological follow-up duration was 39.8 months (range 16.4–101.9 months). None of the 16 patients developed recurrence during the follow-up course. Conclusions In contrast to previous publications that have reported a high rate of recurrence in cases involving nodular enhancement within the original tumor bed, postoperative enhancement in the IAC lateral to the original tumor margin appears to carry much less risk for tumor recurrence. These findings may be helpful when counseling patients on the recommended frequency of postoperative follow-up imaging.
Stereotactic radiosurgery for glossopharyngeal neuralgia: preliminary report of 5 cases
Pollock, Bruce E. , Boes, Christopher J.

Mayo Clinic

Journal of Neurosurgery | July 8, 2011 | Volume: 115 | Issue: 5 | Pages: 936-939

10.3171/2011.5.jns1133 | PMID 21740122 Get It

Object Glossopharyngeal neuralgia (GPN) is a rare pain disorder characterized by severe, stabbing pain of the ear, posterior tongue, and throat. The authors report their early experience of using stereotactic radiosurgery (SRS) as an alternative to posterior fossa surgery for patients with medically resistant GPN. Methods Five patients (3 men, 2 woman) with medically resistant GPN underwent Gamma Knife surgery. The radiosurgical target was the distal portion of the glossopharyngeal and vagus nerves at the jugular foramen (glossopharyngeal meatus). The maximum radiation dose in all cases was 80 Gy. The median follow-up after radiosurgery was 13 months (range 2–19 months). Results Three patients became pain-free at 2 days, 3 days, and 2 weeks, respectively, and were able to discontinue the medications taken preoperatively for their pain. None of these patients have suffered recurrent pain since becoming pain free. Two patients experienced no benefit from the procedure and underwent posterior fossa surgery 2 and 5 months after SRS. Both of these patients continued to have pain after posterior fossa surgery. One of these patients was later discovered to have a head and neck cancer as the cause of his pain. No patient developed hoarseness or dysphagia after radiosurgery. Conclusions This preliminary experience demonstrates that SRS is an option for patients with medically resistant GPN. Additional follow-up and a larger number of patients are needed to demonstrate the long-term safety and optimal radiation dosimetry for this indication.
Comparison of Maternal Milk (Breastmilk) Expression Methods in an African Nursery
Slusher, Tina M. , Slusher, Ida L., Curtis, Beverly, Smith, E. Alistair, Orodriyo, Elizabeth, Awori, Sussane, Nakakeeto, Margaret, Keating, Elizabeth M.

Mayo Clinic

Breastfeeding Medicine | July 8, 2011 | Volume: 7 | Issue: 2 | Pages: 107-111

10.1089/bfm.2011.0008 | PMID 21740276 Get It

Flow Diversion for Intracranial Aneurysms
D’Urso, Pietro Ivo , Lanzino, Giuseppe, Cloft, Harry J. , Kallmes, David F.

Mayo Clinic

Stroke | July 8, 2011 | Volume: 42 | Issue: 8 | Pages: 2363-2368

10.1161/strokeaha.111.620328 | PMID 21737793 Get It

The introduction of flow diverters for treatment of intracranial aneurysms represents a major paradigm shift in the treatment of these lesions. The theoretical hallmark of flow diverters is the treatment of the diseased segment harboring the aneurysm instead of treating the aneurysm itself. Flow diverters are designed to induce disruption of flow near the aneurysm neck while preserving flow into parent vessel and adjacent branches. After flow diversion, intra-aneurysmal thrombosis occurs, followed by shrinkage of the aneurysmal sac as the thrombus organizes and retracts. Preliminary clinical series document effective treatment of wide-neck and/or large and giant aneurysms with acceptable complication rates. However, several questions remain unanswered related to the incidence and mechanisms of aneurysm rupture after treatment with flow diverters, fate of small perforating vessels, and long-term patency rates.
KRAS and Colorectal Cancer: Ethical and Pragmatic Issues in Effecting Real-Time Change in Oncology Clinical Trials and Practice
Blanke, Charles D. , Goldberg, Richard M. , Mooney, Margaret , Roach, Nancy, Saltz, Leonard B. , Meropol, Neal J. , Grothey, Axel , Welch, John J. , Wood, William A. , Saltz, Leonard

Mayo Clinic

The Oncologist | July 8, 2011 | Volume: 16 | Issue: 8 | Pages: 1061-1068

10.1634/theoncologist.2011-0011 | PMID 21737577 Get It

Abstract Systemic therapy has led to a median survival time for patients with advanced colorectal cancer (CRC) almost fourfold longer than that expected with best supportive care, an outcome achieved through combining chemotherapeutic and targeted biologic agents. Although the latter can include anti–epidermal growth factor receptor antibodies, such as cetuximab and panitumumab, we now have strong evidence that patients whose tumors harbor mutated KRAS will not benefit from this class of agent. Acceptance of the reliability and importance of the KRAS data took several years to evolve, however, for a variety of reasons. The timeline from the presentation and publication of small, retrospective phase II studies to widespread acceptance of the KRAS predictive value and changes in behavior—specifically, modifications of ongoing national trials in advanced/metastatic CRC, changes in national guidelines and practice patterns, and adjustments to the labeled indications for the monoclonal antibodies—was lengthy. In this commentary, we discuss whether or not the process of data disclosure regarding KRAS status and treatment of advanced CRC patients was effective in permitting timely decisions regarding ongoing publicly funded clinical trials and whether or not such decisions were rational and ethical. The overall goals are to highlight lessons learned regarding early disclosure of clinical trial results, as well as vetting and adoption of new scientific data, and to propose modifications for handling similar situations in the future.
Activity Limitations and Healthcare Access as Correlates of Frequent Mental Distress in Adults 65 Years and Older
Segev, Zuzana, Arif, Ahmed A. , Rohrer, James E.

Mayo Clinic

Journal of Primary Care & Community Health | July 8, 2011 | Volume: 3 | Issue: 1 | Pages: 17-22

10.1177/2150131911412380 | PMID 23804850 Get It

Objectives: Poor mental health is a major source of distress, disability, and social burden in older adults. The objective of this study was to determine if activity limitation and healthcare access are associated with frequent mental distress (FMD) in adults 65 years and older. Methods: Of the 123 427 study participants aged 65 years or older, 120 445 participants responded to the Behavioral Risk Factors Surveillance System (BRFSS) survey question on number of mentally unhealthy days. Participants who reported having 14 or more mentally unhealthy days during the past 30 days were considered as having FMD. Activity limitation, avoidance of medical care due to cost, and availability of personal doctor were examined for their association with FMD in multivariable logistic regression analysis. Age, sex, race/ethnicity, marital and employment status, emotional support, and life satisfaction were included as potential confounders. Results: The prevalence of FMD in this study population was 6.5% (95% CI = 6.3-6.8) with estimates significantly greater among women (7.2%, 95% CI = 6.9-7.6) as compared to men (5.5%, 95% CI = 5.1-6.0). The odds of FMD were more than 2-fold elevated for those who reported activity limitations due to physical, mental, or emotional problems (adjusted OR = 2.59, 95% CI = 2.33-2.87), and among those who reported health care cost as a barrier to see a doctor (adjusted OR = 2.14, 95% CI = 1.75-2.61). There was no significant relationship between availability of personal doctor and FMD observed in the study. Conclusions: The findings of this study showed that activity limitation and cost of medical care are associated with FMD in the US elderly population.
Left Atrial Size Is a Potent Predictor of Mortality in Mitral Regurgitation Due to Flail Leaflets
Ruşinaru, Dan, Tribouilloy, Christophe, Grigioni, Francesco , Aviérinos, Jean-François , Suri, Rakesh M. , Barbieri, Andréa , Szymanski, Catherine, Ferlito, Marinella, Tafanelli, Laurence, Bursi, Francesca , Mezghani, Sonia, Branzi, Angelo, Modena, Maria Grazia , Enriquez‐Sarano, Maurice , Michelena, Héctor I. , Habib, Gilbert , Enriquez-Sarano, Maurice , Barbieri, Andrea , Bursi, Francesca , Grigioni, Francesco

Mayo Clinic

Circulation: Cardiovascular Imaging | July 8, 2011 | Volume: 4 | Issue: 5 | Pages: 473-481

10.1161/circimaging.110.961011 | PMID 21737598 Get It

Background— Left atrium (LA) enlargement is common in organic mitral regurgitation (MR) and is an emerging prognostic indicator. However, outcome implications of LA enlargement have not been analyzed in the context of routine clinical practice and in a multicenter study. Methods and Results— The Mitral Regurgitation International DAtabase (MIDA) registry enrolls patients with organic MR due to flail leaflets, diagnosed in routine clinical practice, in 5 US and European centers. We investigated the relation between LA diameter and mortality under medical treatment and after mitral surgery in 788 patients in sinus rhythm (64±12 years; median LA, 48 [43 to 52] mm). LA diameter was independently associated with survival after diagnosis (hazard ratio, 1.08 [1.04 to 1.12] per 1 mm increment). Compared with patients with LA <55 mm, those with LA ≥55 mm had lower 8-year overall survival ( P <0.001). LA ≥55 mm independently predicted overall mortality (hazard ratio, 3.67 [1.95 to 6.88]) and cardiac mortality (hazard ratio, 3.74 [1.72 to 8.13]) under medical treatment. The association of LA ≥55 mm and mortality was consistent in subgroups. Similar excess mortality associated with LA ≥55 mm was observed in asymptomatic and symptomatic patients ( P for interaction, 0.77). In patients who underwent mitral surgery, LA ≥55 mm had no impact on postoperative outcome ( P >0.20). Mitral surgery was associated with greater survival benefit in patients with LA ≥55 mm compared with LA <55 mm ( P for interaction, 0.008). Conclusions— In MR caused by flail leaflets, LA diameter ≥55 mm is associated with increased mortality under medical treatment, independent of the presence of symptoms or left ventricular dysfunction.
Measurement of prostate viscoelasticity using Shearwave Dispersion Ultrasound Vibrometry (SDUV): An in vitro study
Urban, Matthew W. , Greenleaf, James F. , Mitri, Farid G., Urban, Matthew W

Mayo Clinic

2010 IEEE International Ultrasonics Symposium | July 7, 2011 | Volume: No volume available | Issue: No issue available | Pages: 1141-1144

10.1109/ultsym.2010.5935723 Get It

Use of Immunohistochemistry Techniques in Patients Exposed to Sulphur Mustard Gas
Chilosi, Marco , Akbari, Hassan , Motiei-Langroudi, Rouzbeh , Harandi, Ali Amini , Shamsaei, Hassan, Tazelaar, Henry D. , Ghanei, Mostafa , Bahadori, Moslem , Tazelaar, Henry D.

Mayo Clinic

Pathology Research International | July 7, 2011 | Volume: 2011 | Issue: No issue available | Pages: 1-7

10.4061/2011/659603 | PMID 21776342 Get It

We performed a pathologic study with further using an immunohistochemical technique (using anti-p63 and anti-CK5) on tissues obtained by open lung biopsy from 18 patients with previous exposure to sulphur mustard (SM) as case group and 8 unexposed patients (control group). The most frequent pathologic diagnosis was constrictive bronchiolitis ( 44.4 % ), followed by respiratory ( 22.2 % ) and chronic cellular bronchiolitis ( 16.7 % ) in the case group, and hypersensitivity bronchiolitis ( 50 % ) in the control group. The pathologic diagnoses were significantly different in the case and control groups ( P = 0.042 ). In slides stained by anti-p63 and anti-CK5, the percent of stained cells and the mean number of epithelial cells were lower in the case group in comparison to the control group. This difference was significant for the mean number of cells stained by anti-CK5 ( P = 0.042 ). Furthermore, there was a significant correlation between pathologic diagnosis and total number of cells and mean number of cells stained with anti-p63 and anti-CK5 ( P value = 0.002, <0.001, 0.044). These results suggest that constrictive bronchiolitis may be the major pathologic consequence of exposure to SM. Moreover, decrease of p63 in respiratory tissues affected by SM may suggest the lack of regenerative capacity in these patients.